Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Freya Meds vs PeptidesRx

Freya Meds
Graded #364

Lower grade

vs+5.499999999999993
PeptidesRx
Graded #247

Higher grade

The verdict

PeptidesRx takes it — 64.1/100 to 58.6/100.

PeptidesRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PeptidesRx is a Fort Worth, TX-based licensed telehealth platform offering physician-supervised compounded semaglutide, tirzepatide, and a broader prescription peptide menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePeptidesRx +18
43
61
Dose & formulationFreya Meds +10
64
54
Clinical oversightPeptidesRx +14
71
85
Labs & monitoringFreya Meds +5
60
55
FulfillmentPeptidesRx +8
62
70
Contract termsEven
55
55
Freya Meds · left barPeptidesRx · right bar

The numbers

MetricFreya MedsPeptidesRx
WeighScore58.6/10064.1/100
GradeCC
Scorecard rank#364#247
Semaglutide$297/mo (compounded)$169/mo (0.25 mg dose, compounded)
Tirzepatide$390/mo (compounded)$309/mo (2.5 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Freya Meds

Graded #364 · C

Strengths

  • GLP-1 specialist — not a multi-category telehealth
  • Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
  • Both semaglutide and tirzepatide available
  • Multi-month discount on quarterly billing
  • Claims 450,000+ enrolled

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Above-average pricing ($250–$390/mo)
  • Compounded only — no brand-name options
  • Now serves 49 U.S. states (one state excluded; specific exclusion not named)
PeptidesRx

Graded #247 · C

Strengths

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Where it loses points

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard